Материалов:
980 144

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 43165

Страница 3 из 4317

Vascular endothelial growth factor inhibitors in the treatment of neovascular age-related macular degeneration by factors from the vascular endothelial growth factor (VEGF) family. Since 2006, the key treatment

Genetic modification of adipose derived stem cells with recombinant plasmid DNA pBud-VEGF-FGF2 results in increased of IL-8 and MCP-1 secretion-angiogenic growth factors VEGF and FGF2 on cytokine production of human adipose derived stem cells (ADSC). Adipose

Case report of application gene construction with VEGF and BMP2 in restoration of tear in the anterior cruciate ligament of a large breed dogVascular endothelial growth factor

Combined Use of Cabozantinib and Nivolumab in Clinical Practice
vascular endothelial growth factor

Human umbilical cord blood mononuclear cells transfected with dual cassette plasmids (VEGF + neurotrophic factor) for the treatment of amyotrophic lateral sclerosis) and vascular endothelial growth factor (VEGF). One of the promising ways of the delivery of supporting neuron

Recombinant Plasmid DNA Construct Encoding Combination of vegf165 and bmp2 cDNAs Stimulates Osteogenesis and Angiogenesis In Vitro-angiogenic vascular endothelial growth factor 165A (VEGF165A) and pro-osteogenic bone morphogenetic protein 2 (BMP2

Application of VEGF inhibitor (aflibercept) in case of Coats retinitis in children component as a result of intravitreal injection of vascular endothelial growth factor inhibitor for a 11

Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia-related pulmonary hypertension and vascular endothelial growth factor (VEGF) with protection from this complication

Comparative Analysis of the Effect of Gene-Activated Grafts Carrying a PBUD-VEGF165A-BMP2 Plasmid on Bone Regeneration in a Rat Femur Defect Model cassette plasmid constructs encoding human vascular endothelial growth factor A (VEGF-A) and bone

Endothelial dysfunction and reduced heart rate variability in patients with metabolic syndrome
underwent the study of heart rate variability. The levels of insulin, endothelin-1, and vascular endothelial

Страница 3 из 4317